Vitux Group AS – Trademark Portfolio
Entity Type: 99
Vitux Group AS holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include C, CONCORDIX, SMART CHEWS, CONCORDIX SMART CHEWS, and CONCORDIX BENEFITS INSIDE.
Brynsveien 11-13
N-0667 Oslo
Showing of trademarks Trademarks
Trademark Classifications
Vitux Group AS's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Frequently Asked Questions
How many trademarks does Vitux Group AS have?
Vitux Group AS has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does Vitux Group AS file in?
Vitux Group AS files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing), Class 29 (Meats & Processed Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Vitux Group AS's most well-known trademarks?
Vitux Group AS's registered trademark portfolio includes well-known marks such as C, CONCORDIX, SMART CHEWS, CONCORDIX SMART CHEWS, and CONCORDIX BENEFITS INSIDE. These are among 5 currently registered trademarks in the portfolio.
What is Vitux Group AS's trademark registration success rate?
Vitux Group AS has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.